EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Persistence of Bacterial Dysbiosis, Cervicovaginal Human Papillomaviruses, and Inflammation in Women Living With HIV-1 After a Year of Antiretroviral Therapy

Andrea Lisco iD, Alessandra Borgognone iD, Christophe Vanpouille iD, Katherine Bricker-Holt iD, Viviane Callier iD, Martha Nason, Ivan Vujkovic-Cvijin iD, Derek Macmath iD, Maura Manion iD, Andrew D Redd iD, Frances Galindo, Sarah Kalibbala und 6 weitere

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag211 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Andrea Lisco und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: HIV Infections, Dysbiosis, Vagina, Cervix Uteri. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NHLBI NIH HHS, Bench to Bedside Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The cervicovaginal microbiome may affect susceptibility to human immunodeficiency virus (HIV) -1 and can in turn influence the prevalence and clinical course of HIV-1 and other sexually transmitted diseases. Because the determinants, immunological correlates, and clinical effects of the dysbiosis observed in women with HIV-1 (WWH) remain elusive, we evaluated the vaginal immunological milieu, cervicovaginal microbiome, and prevalence of human papillomaviruses (HPVs) in antiretroviral-naive WWH over their first year of antiretroviral therapy (ART).

Methods

83 ART-naive Ugandan WWH were enrolled in a longitudinal observational trial. Clinical evaluation and sampling of cervicovaginal secretions and plasma were performed 0, 8, 24, and 52 weeks after ART initiation. 16S ribosomal-RNA-V3−V4 sequencing identified cervicovaginal microbial communities. A multiplex-bead-array assay was used for biomarkers quantification, while a polymerase chain reaction–based hybridization assay was used for HPV genotyping.

Results

Gardnerella was the most abundant genus, with a median relative abundance of 35% before ART, maintaining a high prevalence throughout the study. Vaginal bacterial diversity did not change after ART, although the relative abundance of some genera, including the bacterial vaginosis–associated bacteria Peptostreptococcus and Prevotella, decreased compared with baseline. Inflammatory biomarkers remained elevated in the cervicovaginal compartment despite prompt decreases in plasma. The prevalence of high-risk and low-risk HPV types remained stable despite ART.

Conclusions

Suppression of HIV-1 replication is not sufficient to revert dysbiotic changes, proinflammatory immunological milieu and persistent HPV infections. Exploration of targeted strategies to restore cervicovaginal mucosal immunological functions in WWH is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsDysbiosisVaginaCervix UteriInflammationPapillomavirus InfectionsHuman Papillomavirus VirusesHumansFemaleAdultLongitudinal StudiesMicrobiotaHIV-1UgandaRNA, Ribosomal, 16SPrevalencePapillomaviridae

Stichwörter der Autor:innen

GardnerellaHPVcervicovaginal microbiomeinflammatory biomarkerswomen living with HIV-1

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • IrsiCaixa, Badalona, Catalonia, Spain.
  • Pediatric and Adolescent Gynecology Branch, Eunice Kennedy Shriver National Institute of Child and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
  • Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Office of Biostatistics Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.

ORCID-Profile: Andrea Lisco, Alessandra Borgognone, Christophe Vanpouille, Katherine Bricker-Holt, Viviane Callier, Ivan Vujkovic-Cvijin, Derek Macmath, Maura Manion, Andrew D Redd, Victor Ssempijja, Aggrey Anok, Steven J Reynolds, Anna R Giuliano, Irini Sereti

Förderung

  • NIH HHS
  • NHLBI NIH HHS
  • Bench to Bedside Program
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health

Zitieren

APA

Lisco, A., Borgognone, A., Vanpouille, C., Bricker-Holt, K., Callier, V., Nason, M., Vujkovic-Cvijin, I., Macmath, D., Manion, M., Redd, A. D., Galindo, F., Kalibbala, S., Ssempijja, V., Anok, A., Tomusange, S., Reynolds, S. J., Giuliano, A. R., & Sereti, I. (2026). Persistence of Bacterial Dysbiosis, Cervicovaginal Human Papillomaviruses, and Inflammation in Women Living With HIV-1 After a Year of Antiretroviral Therapy. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag211

Vancouver

Lisco A, Borgognone A, Vanpouille C, Bricker-Holt K, Callier V, Nason M, et al. Persistence of Bacterial Dysbiosis, Cervicovaginal Human Papillomaviruses, and Inflammation in Women Living With HIV-1 After a Year of Antiretroviral Therapy. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag211

BibTeX
@article{Lisco2026,
  author = {Lisco, Andrea and Borgognone, Alessandra and Vanpouille, Christophe and Bricker-Holt, Katherine and Callier, Viviane and Nason, Martha and Vujkovic-Cvijin, Ivan and Macmath, Derek and Manion, Maura and Redd, Andrew D and Galindo, Frances and Kalibbala, Sarah and Ssempijja, Victor and Anok, Aggrey and Tomusange, Stephen and Reynolds, Steven J and Giuliano, Anna R and Sereti, Irini},
  title = {Persistence of Bacterial Dysbiosis, Cervicovaginal Human Papillomaviruses, and Inflammation in Women Living With HIV-1 After a Year of Antiretroviral Therapy},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag211}
}
Kostenlos starten →